Good Day BIO Newsletter

The I am BIO Podcast explores the next frontier for CRISPR: more effective delivery. Plus, nominations are open for BIO’s George Washington Carver and Rosalind Franklin Awards. (476 words, 2 minutes, 22 seconds)  P.S. BIO’s Education Alliance Partner, UCSF, is offering a 10-week virtual master class direct from Silicon Valley, “Entrepreneurship for Life Science/Healthcare,” offered Fall 2024.  Learn more at an info session TODAY, April 23, at 2 PM ET. 

Today is Earth Day, highlighting the importance of addressing plastic pollution—and biotech has a few answers. Continuing on the environment theme, BIO’s Beth Ellikidis spoke to Agri-Pulse about how we can advance biotech innovation. (546 words, 2 minutes, 43 seconds)

A busy week comes to an end with a recap of what policymakers and regulators said at yesterday’s  Agriculture & Environment Summit, plus more news you might have missed. (795 words, 3 minutes, 58 seconds)

A busy week continues, as we kick off the BIO Agriculture & Environment Summit, and recap BIO’s Capitol Hill fly-in. Plus, a new report highlights the societal value of vaccines. (634 words, 3 minutes, 10 seconds)

In a win for patients, the Virginia Governor vetoed legislation establishing a Prescription Drug Affordability Board (PDAB). Meanwhile, yesterday’s hearing on ERISA highlighted AFP and PBM abuses. (620 words, 3 minutes, 6 seconds)

A new study, led by BIO’s Dr. Leah Buchman, shows the link between public trust in regulators and support for gene drive in agriculture. Plus, April is Primary Immunodeficiency Month—the Immune Deficiency Foundation shares five things you should know. (609 words, 3 minutes, 2 seconds)

Happy Tax Day. We take a deep dive into what biotech is doing about bird flu, and why biotech should be part of the conversation this week during the U.N. General Assembly's Sustainability Week. (576 words, 2 minutes, 52 seconds)

Yesterday, the House Ways & Means Committee revived discussion of legislation to restore immediate R&D expensing—we recap. Plus, Sen. Bernie Sanders’ idea for a “long COVID moonshot” is admirable—but price controls could thwart the companies already researching this disease (and others). (544 words, 2 minutes, 43 seconds)

We recap what BIO Board member company Ginkgo Bioworks said about AI and IP on Capitol Hill yesterday—plus, BIO comments on a proposed update to the Medicaid Drug Rebate Program (MDRP) and BIO CEO John F. Crowley wins a leadership award from Life Sciences PA. (881 words, 4 minutes, 24 seconds)

PCOS is underrecognized and underresearched—yet it’s a common cause of infertility. We look at what should be done—plus, a “lab on wheels” that brings biotech to rural students in Maine. (585 words, 2 minutes, 55 seconds)